Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Beka, S; Strauss, RW; Podkowinski, D; Mursch-Edlmayr, AS; Mariacher, S; Hofer, AS; Bolz, M.
Efficacy of a Disease Management Program of a Tertiary Center and Ophthalmologic Practitioners for the Treatment of Neovascular Age-Related Macular Degeneration.
Ophthalmologica. 2022; 245(1):10-18
Doi: 10.1159/000517188
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Strauß Rupert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- PURPOSE: The aim of the study was to examine real-world data of patients with neovascular age-related macular degeneration (nAMD) within a disease management program (DMP) treated with anti-VEGF. METHODS: A monocentric, retrospective chart review of 379 eyes of a local DMP was conducted at the Department of Ophthalmology, Kepler University Clinic Linz. Eyes were treated either with bevacizumab or aflibercept using a pro re nata scheme, consisting of 3 injections every 4 weeks in case of presence of disease activity. The observational period was up to 24 months. Disease activity was monitored by visual acuity (VA), clinical examination, and optical coherence tomography (OCT). For (re-)treatments, ophthalmologic practitioners referred patients directly to the intravitreal injection, avoiding redundant examinations. RESULTS: VA improved significantly for all patients after 2 months (logMAR 0.47 ± 0.36; p = 0.000) compared to baseline (0.55 ± 0.37), and for the aflibercept group for up to 6 months (0.36 ± 0.27; p = 0.018). After 12 months, VA remained stable without further significant improvement and decreased by 24 months compared to baseline. The median number of injections was 6 over the first 12 months and 4 in the second year. CONCLUSION: Data revealed the efficacy of a DMP for nAMD involving both ophthalmologic practitioners and a tertiary center. Avoiding redundant examinations increased the efficacy of a clinical setting.
- Find related publications in this database (using NLM MeSH Indexing)
- Angiogenesis Inhibitors - administration & dosage
- Disease Management - administration & dosage
- Follow-Up Studies - administration & dosage
- Humans - administration & dosage
- Intravitreal Injections - administration & dosage
- Macular Degeneration - drug therapy
- Ranibizumab - administration & dosage
- Receptors, Vascular Endothelial Growth Factor - administration & dosage
- Recombinant Fusion Proteins - therapeutic use
- Retrospective Studies - administration & dosage
- Tomography, Optical Coherence - administration & dosage
- Treatment Outcome - administration & dosage
- Find related publications in this database (Keywords)
- Age-related macular degeneration
- Medical retina
- Retina
- Disease management
- Public health